ACE inhibitors are linked to increased lung cancer risk, study finds

  title={ACE inhibitors are linked to increased lung cancer risk, study finds},
  author={Zosia Kmietowicz},
  journal={British Medical Journal},
  • Z. Kmietowicz
  • Published 24 October 2018
  • Medicine
  • British Medical Journal
Angiotensin converting enzyme inhibitors (ACEIs) are associated with a higher risk of lung cancer than angiotensin receptor blockers (ARBs), especially if used for more than five years, a study in The BMJ has found.1 Although the risk to individual patients is modest, the absolute numbers of patients at risk for lung cancer is potentially large because ACEIs are widely prescribed, said the researchers. Evidence suggests that ACEIs increase the risk of lung cancer through the build-up of… 

The effects of two types of renin-angiotensin system inhibitors on the hypertension induced by new pressor protein associated with beta-factor XIIa in rats

It could be concluded that losartan could improve hypertension in normal rats, while captopril deteriorated hypertension in bilaterally nephrectomized rats in this hypertension model.

A modular map of Bradykinin-mediated inflammatory signaling network

The bradykinin-mediated signaling pathway map will facilitate the identification of novel candidates as therapeutic targets for diseases associated with dysregulated brady Kinin signaling.

Effect of miR-181b on the biological characteristics and clinical drug resistance of small cell lung cancer by targeting gene ACE2

Objective To clarify the effect of miR-181b on the biological function of SCLC, to detect and verify its downstream target gene ACE2, and to explore the effect of clinical resistance on SCLC in

Peptide Chemistry's Contribution to the Treatment of the Majority of Serious Illnesses: Peptide Antitumors.

This review focuses on the reports regarding peptide compounds showing their biological activity especially as anti-cancer agents, including Bleomycin, Cryptophycin and its analogues, Bombesin, Bradykinin and prophyrin family.



Angiotensin converting enzyme inhibitors and lung cancer

Any extra risk must be balanced against the mortality benefits of ACEI use to decide whether to continue using ACEI in patients with a history of heart attack or stroke.

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study

In this population based cohort study, the use of ACEIs was associated with an increased risk of lung cancer, and the association was particularly elevated among people using ACEIs for more than five years.